Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
ACS Macro Lett ; 12(4): 510-517, 2023 04 18.
Artigo em Inglês | MEDLINE | ID: mdl-37012585

RESUMO

Four-armed poly(ethylene glycol) (PEG)s are essential hydrophilic polymers extensively utilized to prepare PEG hydrogels, which are valuable tissue scaffolds. When hydrogels are used in vivo, they eventually dissociate due to cleavage of the backbone structure. When the cleavage occurs at the cross-linking point, the hydrogel elutes as an original polymer unit, i.e., four-armed PEG. Although four-armed PEGs have been utilized as subcutaneously implanted biomaterials, the diffusion, biodistribution, and clearance behavior of four-armed PEG from the skin are not fully understood. This paper investigates time-wise diffusion from the skin, biodistribution to distant organs, and clearance of fluorescence-labeled four-armed PEGs with molecular weight (Mw) ranging from 5-40 kg/mol subcutaneously injected into the back of mice. Changes over time indicated that the fate of subcutaneously injected PEGs is Mw-dependent. Four-armed PEGs with Mw ≤ 10 kg/mol gradually diffused to deep adipose tissue beneath the injection site and distributed dominantly to distant organs, such as the kidney. PEGs with Mw ≥ 20 kg/mol stagnated in the skin and deep adipose tissue and were mainly delivered to the heart, lung, and liver. The fundamental understanding of the Mw-dependent behavior of four-armed PEGs is beneficial for preparing biomaterials using PEGs, providing a reference in the field of tissue engineering.


Assuntos
Polietilenoglicóis , Polímeros , Camundongos , Animais , Polietilenoglicóis/química , Distribuição Tecidual , Peso Molecular , Hidrogéis/química , Materiais Biocompatíveis
2.
Int J Neuropsychopharmacol ; 22(1): 19-27, 2019 01 01.
Artigo em Inglês | MEDLINE | ID: mdl-30239793

RESUMO

Background: Cigarette smoking is consistently more common among schizophrenia patients than the general population worldwide; however, the findings of studies in Japan are inconsistent. Recently, the smoking rate has gradually decreased among the general population. Methods: We performed a meta-analysis of smoking status in a large Japanese cohort of (1) 1845 schizophrenia patients and 196845 general population and (2) 842 schizophrenia patients and 766 psychiatrically healthy controls from 12 studies over a 25-year period, including 301 patients and 131 controls from our study. Results: In our case-control sample, schizophrenia patients had a significantly higher smoking rate than healthy controls (P=.031). The proportion of heavy smokers (P=.027) and the number of cigarettes smoked per day (P=8.20×10-3) were significantly higher among schizophrenia patients than healthy controls. For the smokers in the schizophrenia group, atypical antipsychotics dosage was positively correlated with cigarettes per day (P=1.00×10-3). A meta-analysis found that schizophrenia patients had a higher smoking rate than the general population for both men (OR=1.53, P=.035; schizophrenia patients, 52.9%; general population, 40.1%) and women (OR=2.40, P=1.08×10-5; schizophrenia patients, 24.4%; general population, 11.8%). In addition, male schizophrenia patients had a higher smoking rate than male healthy controls (OR=2.84, P=9.48×10-3; schizophrenia patients, 53.6%; healthy controls, 32.9%), but the difference was not significant for women (OR=1.36, P=.53; schizophrenia patients, 17.0%; healthy controls,14.1%). Among both males and females, schizophrenia patients had a higher smoking rate than both the general population (OR=1.88, P=2.60×10-5) and healthy controls (OR=2.05, P=.018). These rates were not affected by the patients' recruitment year (P>.05). The cigarettes per day values of schizophrenia patients and the general population were 22.0 and 18.8, respectively. Conclusions: Schizophrenia patients are approximately 2 times more likely to smoke than the general population and healthy controls based on data collected over a decade in Japan.


Assuntos
Esquizofrenia/epidemiologia , Fumar/epidemiologia , Feminino , Humanos , Japão/epidemiologia , Masculino , Esquizofrenia/complicações , Produtos do Tabaco
3.
Biochem J ; 460(3): 459-71, 2014 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-24635384

RESUMO

The transcription factor SF-1 (steroidogenic factor-1) is a master regulator of steroidogenesis. Previously, we have found that SF-1 induces the differentiation of mesenchymal stem cells into steroidogenic cells. To elucidate the molecular mechanisms of SF-1-mediated functions, we attempted to identify protein components of the SF-1 nuclear protein complex in differentiated cells. SF-1 immunoaffinity chromatography followed by MS/MS analysis was performed, and 24 proteins were identified. Among these proteins, we focused on C/EBPß (CCAAT/enhancer-binding protein ß), which is an essential transcription factor for ovulation and luteinization, as the transcriptional mechanisms of C/EBPß working together with SF-1 are poorly understood. C/EBPß knockdown attenuated cAMP-induced progesterone production in granulosa tumour-derived KGN cells by altering STAR (steroidogenic acute regulatory protein), CYP11A1 (cytochrome P450, family 11, subfamily A, polypeptide 1) and HSD3B2 (hydroxy-δ-5-steroid dehydrogenase, 3ß- and steroid δ-isomerase 2) expression. EMSA and ChIP assays revealed novel C/EBPß-binding sites in the upstream regions of the HSD3B2 and CYP11A1 genes. These interactions were enhanced by cAMP stimulation. Luciferase assays showed that C/EBPß-responsive regions were found in each promoter and C/EBPß is involved in the cAMP-induced transcriptional activity of these genes together with SF-1. These results indicate that C/EBPß is an important mediator of progesterone production by working together with SF-1, especially under tropic hormone-stimulated conditions.


Assuntos
Proteína beta Intensificadora de Ligação a CCAAT/metabolismo , Progesterona/biossíntese , Fator Esteroidogênico 1/fisiologia , Animais , Proteína beta Intensificadora de Ligação a CCAAT/genética , Células Cultivadas , Enzima de Clivagem da Cadeia Lateral do Colesterol/genética , Regulação da Expressão Gênica , Humanos , Camundongos , Fosfoproteínas , Progesterona/genética , Progesterona Redutase/genética , Espectrometria de Massas em Tandem
4.
Dent Mater J ; 27(2): 203-10, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18540393

RESUMO

This study was an examination of the galvanic corrosion of ferritic stainless steels, namely SUS 444, SUS XM27, and SUS 447J1, in contact with a Fe-Pt magnet. The surface area ratio of each stainless steel to the Fe-Pt magnet was set at 1/1 or 1/10. Galvanic corrosion between the stainless steels and the magnet was evaluated by the amount of released ions and the electrochemical properties in 0.9% NaCl solution. Although each stainless steel showed sufficient corrosion resistance for clinical use, the amount of ions released from each tended to increase when the stainless steel was in contact with the magnet. When the surface area ratio was reduced to 1/10, the amount of Fe ions released from the stainless steels increased significantly more than when there was no contact. Since contact with the magnet which possessed an extremely noble potential created a very corrosive environment for the stainless steels, 447J1 was thus the recommended choice against a corrosion exposure as such.


Assuntos
Ligas Dentárias/química , Retenção em Prótese Dentária/instrumentação , Magnetismo/instrumentação , Corrosão , Eletroquímica , Íons , Teste de Materiais , Cloreto de Sódio , Aço Inoxidável/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA